Combination therapy with corticosteroids ups infection risk by almost 5-fold By Neil Canavan Berlin, Germany—Taking another step forward toward the realization of personalized medicine in rheumatology, German researchers presented the results of a new study that validated their original RABBIT (Rheumatoide Arthritis: Beobach­tung der Biologika-Thera­pie) biologic register for rheumatoid arthritis (RA) risk score.
By Alan Menter, MD Chief of Dermatology, and Director, Dermatology Residency Program, Baylor University Medical Center, Dallas, TX Psoriasis and psoriatic arthritis (PsA) have been intimately linked for only decades. Multi­ple questions remain about the true relationship between psoriasis and PsA.
By Mary Mosley New recommendations for the management of lupus nephritis (LN) call for a renal biopsy at the earliest sign of kidney dysfunction to guide the use of immunosuppressive treatment in patients with systemic lupus erythematosus (SLE). The goal for treatment is a complete renal response, defined as proteinuria <0.5 g per 24 hours, with normal or near-normal renal function.
By Alice Goodman Adalimumab plus methotrexate inhibited both joint erosion and joint space narrowing in patients with early rheumatoid arthritis (RA), and this beneficial effect was independent of disease activity.
Risk is related to many disease factors, including comorbidities and increased age By Alice Goodman Patients with rheumatoid arthritis (RA) are at increased risk for infection. Researchers at the Mayo Clinic have developed a new risk score that can predict the risk of serious infection in patients with RA. The risk score was validated in a recent study in 2 cohorts of patients with RA (Crowson CS, et al. Arthritis Rheum. 2012;64:2847-2855).
Page 1 of 3
Results 1 - 10 of 22
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology